Published in Radiology on January 01, 2010
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology (2014) 1.33
APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review. Int J Hepatol (2011) 1.24
Infiltrating hepatocellular carcinoma: seeing the tree through the forest. J Gastrointest Surg (2011) 1.11
Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy. J Hematol Oncol (2013) 0.97
Radiological Diagnosis of Portal/Mesenteric Vein Occlusion. Viszeralmedizin (2014) 0.93
Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery. HPB (Oxford) (2015) 0.84
Added value of diffusion-weighted acquisitions in MRI of the abdomen and pelvis. AJR Am J Roentgenol (2014) 0.81
MRI of hepatocellular carcinoma: an update of current practices. Diagn Interv Radiol (2014) 0.81
Differentiation of neoplastic from bland macroscopic portal vein thrombi using dual-energy spectral CT imaging: a pilot study. Eur Radiol (2012) 0.81
Imaging Diagnosis of Splanchnic Venous Thrombosis. Gastroenterol Res Pract (2015) 0.80
Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement. Oncotarget (2016) 0.79
Characterization of malignant thrombus in an invasive thymoma with intravascular growth. J Radiol Case Rep (2013) 0.79
Investigation of Apparent Diffusion Coefficient from Ultra-high b-Values in Parkinson's Disease. Eur Radiol (2015) 0.77
Limited value of diffusion-weighted MR imaging for differentiating bland from malignant portal venous thrombi. Radiology (2010) 0.77
Extensive tumor thrombus of hepatocellular carcinoma in the entire portal venous system detected on fluorodeoxyglucose positron emission tomography computed tomography. Indian J Nucl Med (2013) 0.77
Hepatocellular Carcinoma and Diffusion-Weighted MRI: Detection and Evaluation of Treatment Response. J Cancer (2016) 0.77
Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma. World J Gastroenterol (2015) 0.76
Prognostication and response assessment in liver and pancreatic tumors: The new imaging. World J Gastroenterol (2015) 0.76
Differentiation of bland from neoplastic thrombus of the portal vein in patients with hepatocellular carcinoma: application of susceptibility-weighted MR imaging. BMC Cancer (2014) 0.75
Morphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine. Hepat Med (2010) 0.75
Giant cavernous hemangioma coexistent with diffuse hepatic hemangiomatosis presenting as portal vein thrombosis and hepatic lobar atrophy. Ultrasonography (2013) 0.75
Cross-sectional imaging of congenital and acquired abnormalities of the portal venous system. Diagn Interv Radiol (2016) 0.75
Multiparametric MRI in differentiating pulmonary artery sarcoma and pulmonary thromboembolism: a preliminary experience. Diagn Interv Radiol (2016) 0.75
Diffusion-Weighted MRI of Malignant versus Benign Portal Vein Thrombosis. Korean J Radiol (2016) 0.75
Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates. World J Hepatol (2017) 0.75
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med (2004) 9.80
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med (2003) 9.09
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. J Clin Oncol (2009) 4.54
Biomarkers of response and resistance to antiangiogenic therapy. Nat Rev Clin Oncol (2009) 4.17
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet (2011) 3.92
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol (2005) 3.83
Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology (2010) 3.60
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study. J Clin Oncol (2009) 3.39
Recent measures to improve radiology reporting: perspectives from primary care physicians. J Am Coll Radiol (2012) 3.32
Adult intestinal intussusception: CT appearances and identification of a causative lead point. Radiographics (2006) 3.22
Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology (2005) 3.01
Case records of the Massachusetts General Hospital. Case 15-2006. A 46-year-old woman with sudden onset of abdominal distention. N Engl J Med (2006) 2.92
Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics (2009) 2.79
Urine leaks and urinomas: diagnosis and imaging-guided intervention. Radiographics (2003) 2.73
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics (2009) 2.47
Acute epiploic appendagitis and its mimics. Radiographics (2005) 2.46
CT appearance of acute appendagitis. AJR Am J Roentgenol (2004) 2.39
Pancreatic cysts 3 cm or smaller: how aggressive should treatment be? Radiology (2006) 2.35
Radiation dose reduction at multidetector CT with adaptive statistical iterative reconstruction for evaluation of urolithiasis: how low can we go? Radiology (2012) 2.35
Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg (2005) 2.27
Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology (2008) 2.27
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study. Lancet Oncol (2009) 2.23
Reducing abdominal CT radiation dose with adaptive statistical iterative reconstruction technique. Invest Radiol (2010) 2.23
Important imaging finding e-mail alert system: experience after 3 years of implementation. Radiology (2009) 2.20
HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol (2011) 2.10
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 27-2003. A 36-year-old man with recurrent epigastric pain and elevated amylase levels. N Engl J Med (2003) 2.09
Body CT scanning in young adults: examination indications, patient outcomes, and risk of radiation-induced cancer. Radiology (2013) 2.09
Dropped appendicolith: CT findings and implications for management. AJR Am J Roentgenol (2008) 2.03
Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics (2005) 2.03
CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology (2002) 1.98
Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut (2011) 1.94
Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology (2005) 1.91
Pheochromocytoma: an imaging chameleon. Radiographics (2004) 1.84
Radiation dose reduction with Sinogram Affirmed Iterative Reconstruction technique for abdominal computed tomography. J Comput Assist Tomogr (2012) 1.82
Transgluteal approach for percutaneous drainage of deep pelvic abscesses: 154 cases. Radiology (2003) 1.78
FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience. Oncologist (2013) 1.76
Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology (2011) 1.73
Image-guided percutaneous splenic interventions. Radiographics (2012) 1.73
Uterine smooth-muscle tumors with unusual growth patterns: imaging with pathologic correlation. AJR Am J Roentgenol (2007) 1.72
EUS-guided injection of paclitaxel (OncoGel) provides therapeutic drug concentrations in the porcine pancreas (with video). Gastrointest Endosc (2006) 1.69
Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients. AJR Am J Roentgenol (2009) 1.68
Body perfusion CT: technique, clinical applications, and advances. Radiol Clin North Am (2009) 1.67
Venous thromboembolism: indirect CT venography during CT pulmonary angiography--should the pelvis be imaged? Radiology (2008) 1.65
Determination of renal stone composition in phantom and patients using single-source dual-energy computed tomography. J Comput Assist Tomogr (2013) 1.64
Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study. J Gastroenterol Hepatol (2008) 1.62
Differential renal function estimation using computerized tomography based renal parenchymal volume measurement. J Urol (2010) 1.62
Vascular and biliary variants in the liver: implications for liver surgery. Radiographics (2008) 1.62
Concentration-dependent ablation of pancreatic tissue by EUS-guided ethanol injection. Gastrointest Endosc (2007) 1.61
Causes of renal forniceal rupture. BJU Int (2011) 1.60
Impact of obesity on medical imaging and image-guided intervention. AJR Am J Roentgenol (2007) 1.58
Incidental adrenal lesions: accuracy of characterization with contrast-enhanced washout multidetector CT--10-minute delayed imaging protocol revisited in a large patient cohort. Radiology (2010) 1.49
Clinical impact of PET/MR imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients--a hypothesis-generating exploratory study. Radiology (2013) 1.46
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma. Cancer (2004) 1.45
Case records of the Massachusetts General Hospital. Case 13-2006. A 50-year-old man with a painful bone mass and lesions in the liver. N Engl J Med (2006) 1.42
Rare benign and malignant appendiceal lesions: spectrum of computed tomography findings with pathologic correlation. J Comput Assist Tomogr (2003) 1.38
Percutaneous hepatic abscess drainage: do multiple abscesses or multiloculated abscesses preclude drainage or affect outcome? J Vasc Interv Radiol (2009) 1.34
Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST). Invest Radiol (2012) 1.33
Imaging diagnosis of cystic pancreatic lesions: pseudocyst versus nonpseudocyst. Radiographics (2005) 1.32
Low-dose CT examinations in Crohn's disease: Impact on image quality, diagnostic performance, and radiation dose. AJR Am J Roentgenol (2010) 1.31
Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance. Am J Surg Pathol (2011) 1.30
Diagnostic accuracy of laxative-free computed tomographic colonography for detection of adenomatous polyps in asymptomatic adults: a prospective evaluation. Ann Intern Med (2012) 1.29
Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma. Oncologist (2008) 1.27
PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR Am J Roentgenol (2009) 1.26
Significance of incidental thyroid lesions detected on CT: correlation among CT, sonography, and pathology. AJR Am J Roentgenol (2006) 1.22
Low-dose MDCT and CT enterography of patients with Crohn disease: feasibility of adaptive statistical iterative reconstruction. AJR Am J Roentgenol (2011) 1.22
Effect of obesity on image quality: fifteen-year longitudinal study for evaluation of dictated radiology reports. Radiology (2006) 1.22
Low-dose CT of the abdomen: evaluation of image improvement with use of noise reduction filters pilot study. Radiology (2003) 1.20
MR imaging of the acute abdomen and pelvis: acute appendicitis and beyond. Radiographics (2007) 1.20
Pancreatic tissue sampling guided by EUS, CT/US, and surgery: a comparison of sensitivity and specificity. Gastrointest Endosc (2002) 1.19
Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP. Radiology (2006) 1.19
Tagging-based, electronically cleansed CT colonography: evaluation of patient comfort and image readability. Radiology (2006) 1.18
Neoplasms of the perivascular epithelioid cell involving the abdomen and the pelvis: cross-sectional imaging findings. J Comput Assist Tomogr (2007) 1.16
Cystic lymph node metastases in papillary thyroid carcinoma. AJR Am J Roentgenol (2002) 1.16
Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II study. Clin Cancer Res (2013) 1.16
Percutaneous abscess drainage in Crohn disease: technical success and short- and long-term outcomes during 14 years. Radiology (2002) 1.15
Polyp size at CT colonography after electronic subtraction cleansing in an anthropomorphic colon phantom. Radiology (2005) 1.15
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. AJR Am J Roentgenol (2005) 1.14
What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma? Oncologist (2006) 1.14
Bowel hot spots at PET-CT. Radiographics (2007) 1.14
Comparative performance of MDCT and MRI with MR cholangiopancreatography in characterizing small pancreatic cysts. AJR Am J Roentgenol (2009) 1.12
CT-guided transgluteal drainage of deep pelvic abscesses: indications, technique, procedure-related complications, and clinical outcome. Radiographics (2002) 1.11
A pilot study of natural orifice transanal endoscopic total mesorectal excision with laparoscopic assistance for rectal cancer. Surg Endosc (2013) 1.11
Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas. Ann Surg Oncol (2010) 1.11
Digital subtraction bowel cleansing for CT colonography using morphological and linear filtration methods. IEEE Trans Med Imaging (2004) 1.10
Radiological measurement of breast cancer metastases to lung and liver: comparison between WHO (bidimensional) and RECIST (unidimensional) guidelines. J Comput Assist Tomogr (2003) 1.09
Twenty-three years of the Warshaw operation for distal pancreatectomy with preservation of the spleen. Ann Surg (2011) 1.09
New and evolving concepts in the imaging and management of urolithiasis: urologists' perspective. Radiographics (2010) 1.09
Cholangiocarcinoma: current and novel imaging techniques. Radiographics (2008) 1.09